Russell 3000

Melinda D. Whittington

Melinda Whittington was named President and CEO of La-Z-Boy after serving as chief financial officer. In that capacity, she led a global finance and accounting team responsible for external reporting,

Melinda D. Whittington Read More »

Melinda Whittington was named President and CEO of La-Z-Boy after serving as chief financial officer. In that capacity, she led a global finance and accounting team responsible for external reporting,

MartineRothblatt

Martine A. Rothblatt, Ph.D.

Dr. Martine A. Rothblatt is Chair, CEO & Founder of United Therapeutics Corp., a Chief Executive Officer at Revivicor, Inc. and a President & CEOat Lung Biotechnology PBC. Martine was

Martine A. Rothblatt, Ph.D. Read More »

Dr. Martine A. Rothblatt is Chair, CEO & Founder of United Therapeutics Corp., a Chief Executive Officer at Revivicor, Inc. and a President & CEOat Lung Biotechnology PBC. Martine was

MaryDillon

Mary N. Dillon

President and Chief Executive Officer of Foot Locker, Inc. Mary N. Dillon is the President and Chief Executive Officer of Foot Locker, Inc., where she is responsible for overseeing all

Mary N. Dillon Read More »

President and Chief Executive Officer of Foot Locker, Inc. Mary N. Dillon is the President and Chief Executive Officer of Foot Locker, Inc., where she is responsible for overseeing all

Maria M. Pope

As an advocate for sustainable energy solutions nationwide, Maria Pope uses her authority as CEO, President and board member of Portland General Electric to provide affordable, clean energy to all

Maria M. Pope Read More »

As an advocate for sustainable energy solutions nationwide, Maria Pope uses her authority as CEO, President and board member of Portland General Electric to provide affordable, clean energy to all

Maria Palasis, Ph.D.

Maria Palasis, Ph.D., is the CEO of Lyra Therapeutics, Inc., a biopharmaceutical company focused on developing innovative drug delivery solutions for chronic respiratory conditions. Dr. Palasis’s leadership is characterized by

Maria Palasis, Ph.D. Read More »

Maria Palasis, Ph.D., is the CEO of Lyra Therapeutics, Inc., a biopharmaceutical company focused on developing innovative drug delivery solutions for chronic respiratory conditions. Dr. Palasis’s leadership is characterized by